J. Frew

2.0k total citations
30 papers, 462 citations indexed

About

J. Frew is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, J. Frew has authored 30 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 11 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Surgery. Recurrent topics in J. Frew's work include Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (11 papers) and Bladder and Urothelial Cancer Treatments (5 papers). J. Frew is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (11 papers) and Bladder and Urothelial Cancer Treatments (5 papers). J. Frew collaborates with scholars based in United Kingdom, Canada and Australia. J. Frew's co-authors include Charles Kelly, Santhanam Sundar, Robert J. Jones, Simon J. Crabb, Syed A. Hussain, Thomas Powles, Daniel M. Berney, Andrew Stockdale, Robert Huddart and Simon Chowdhury and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

J. Frew

28 papers receiving 457 citations

Peers

Countries citing papers authored by J. Frew

Since Specialization

Citations

This map shows the geographic impact of J. Frew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Frew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Frew more than expected).

Fields of papers citing papers by J. Frew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Frew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Frew. The network helps show where J. Frew may publish in the future.

Co-authorship network of co-authors of J. Frew

This figure shows the co-authorship network connecting the top 25 collaborators of J. Frew. A scholar is included among the top collaborators of J. Frew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Frew. J. Frew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Stereotactic Body Radiotherapy for Oligoprogression in Castration-Resistant Prostate Cancer: Early Toxicity Analysis of the TRAP Trial	Clinical Oncology	Priyanka Patel, Alison Reid et al.	2
2	3381: Primary endpoint analysis of TRAP, first prospective Phase II trial of SBRT to oligoprogressive disease prostate cancer (NCT03644303)	Radiotherapy and Oncology	Priyanka Patel, Gerhardt Attard et al.	2
3	The first patients treated with MR-CBCT soft-tissue matching in a MR-only prostate radiotherapy pathway	Radiography	J. Wyatt, R. Pearson et al.	3
4	A randomized, double blind, biomarker selected, phase II clinical trial of maintenance PARP inhibition following chemotherapy for metastatic urothelial carcinoma (mUC): Final analysis of the ATLANTIS rucaparib arm.	Journal of Clinical Oncology	Simon J. Crabb, Syed A. Hussain et al.	17
5	Optimising Radium 223 Therapy for Metastatic Castration-Resistant Prostate Cancer –5-year Real-World Outcome: Focusing on Treatment Sequence and Quality of Life	Clinical Oncology	Xue Jiang, R. Pearson et al.	13
6	Prostate Ultrahypofractionation – Rising to Challenges Presents Opportunities in the COVID-19 Era	Clinical Oncology	William J. Griffiths, J. Frew et al.	1
7	Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)	International Journal of Radiation OncologyBiologyPhysics	David P. Dearnaley, Clare Griffin et al.	43
8	Diffusion-weighted MRI for Early Response Assessment in the Treatment of Bladder Cancer	Clinical Oncology	R. Pearson, Piotr Pieniążek et al.	1
9	Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2–Positive Metastatic Bladder Cancer	Journal of Clinical Oncology	Thomas Powles, Robert Huddart et al.	142
10	The Results of Low-Dose Total Skin Electron Beam Radiation Therapy (TSEB) in Patients With Mycosis Fungoides From the UK Cutaneous Lymphoma Group	International Journal of Radiation OncologyBiologyPhysics	Stephen Morris, Julia Scarisbrick et al.	54
11	An update on clinical outcome data for a phase II randomized study comparing androgen deprivation therapy plus docetaxel versus androgen deprivation therapy alone in men with locally advanced/metastatic hormone sensitive prostate cancer.	Journal of Clinical Oncology	J. Frew, R. McMenemin et al.	1
12	Total Lymphoid Irradiation (TLI) for the Management of Bronchiolitis Obliterans Syndrome (BOS) Post Lung Transplant: A Single Centre Experience	The Journal of Heart and Lung Transplantation	Ross Miller, J. Frew et al.	2
13	Evaluation of early response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using dynamic contrast-enhanced MRI and diffusion weighted MRI: MARBLE study.	Journal of Clinical Oncology	Piotr Pieniążek, Rakesh Heer et al.	2
14	Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non–castration-resistant prostate cancer	Urologic Oncology Seminars and Original Investigations	Prabhakar Rajan, J. Frew et al.	4
15	Variability in prostate and seminal vesicle delineations defined on magnetic resonance images, a multi-observer, -center and -sequence study	Radiation Oncology	Tufve Nyholm, Joakim Jönsson et al.	37
16	Variation in Radiotherapy Target Volume Definition, Dose to Organs at Risk and Clinical Target Volumes using Anatomic (Computed Tomography) versus Combined Anatomic and Molecular Imaging (Positron Emission Tomography/Computed Tomography): Intensity-modulated Radiotherapy Delivered using a Tomotherapy Hi Art Machine: Final Results of the VortigERN Study	Clinical Oncology	Sanjoy Chatterjee, J. Frew et al.	21
17	The Management of Children with Lymphomas	Clinical Oncology	J. Frew, Joanne Lewis et al.	3
18	Priorities for the Head and Neck Cancer Patient, their Companion and Members of the Multidisciplinary Team and Decision Regret	Clinical Oncology	J. Frew, Jennifer Adam et al.	56
19	A Patient with Asymmetric Parotid Uptake on a Diagnostic Iodine-131 Scan during Thyroid Cancer Follow-Up	Thyroid	J. Frew, Ujjal K. Mallick et al.	1
20	Vascular compression of the optic nerves relieved by anastomosis of carotid artery to jugular vein.	Journal of Neurology Neurosurgery & Psychiatry	J. Frew et al.	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact